- Home
- CPHI vs PRSO Comparison
CPHI vs PRSO Comparison
Compare CPHI & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- PRSO
- Stock Information
- Founded
- CPHI N/A
- PRSO 2008
- Country
- CPHI China
- PRSO United States
- Employees
- CPHI N/A
- PRSO N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- CPHI Health Care
- PRSO Technology
- Exchange
- CPHI Nasdaq
- PRSO Nasdaq
- Market Cap
- CPHI 4.0M
- PRSO 3.3M
- IPO Year
- CPHI N/A
- PRSO 2001
- Fundamental
- Price
- CPHI $0.21
- PRSO $0.94
- Analyst Decision
- CPHI
- PRSO Strong Buy
- Analyst Count
- CPHI 0
- PRSO 2
- Target Price
- CPHI N/A
- PRSO $3.38
- AVG Volume (30 Days)
- CPHI 701.9K
- PRSO 76.9K
- Earning Date
- CPHI 03-31-2025
- PRSO 03-17-2025
- Dividend Yield
- CPHI N/A
- PRSO N/A
- EPS Growth
- CPHI N/A
- PRSO N/A
- EPS
- CPHI N/A
- PRSO N/A
- Revenue
- CPHI $5,544,620.00
- PRSO $12,728,000.00
- Revenue This Year
- CPHI N/A
- PRSO $9.59
- Revenue Next Year
- CPHI N/A
- PRSO $1.63
- P/E Ratio
- CPHI N/A
- PRSO N/A
- Revenue Growth
- CPHI N/A
- PRSO N/A
- 52 Week Low
- CPHI $0.13
- PRSO $0.73
- 52 Week High
- CPHI $0.50
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- CPHI 48.21
- PRSO 50.19
- Support Level
- CPHI $0.19
- PRSO $0.82
- Resistance Level
- CPHI $0.24
- PRSO $0.92
- Average True Range (ATR)
- CPHI 0.02
- PRSO 0.07
- MACD
- CPHI 0.00
- PRSO 0.02
- Stochastic Oscillator
- CPHI 46.67
- PRSO 60.38
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.